Alec Machiels - Dec 15, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Stock symbol
APLS
Transactions as of
Dec 15, 2022
Transactions value $
-$62,100
Form type
4
Date filed
12/19/2022, 03:37 PM
Previous filing
Nov 17, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $3.34K +1.25K +0.47% $2.67* 265K Dec 15, 2022 Direct
transaction APLS Common Stock Sale -$65.4K -1.25K -0.47% $52.35 264K Dec 15, 2022 Direct F1
holding APLS Common Stock 250K Dec 15, 2022 Indirect Owner (Bauhaus 1 LLC) F2
holding APLS Common Stock 12K Dec 15, 2022 Indirect Owner (Owned by Spouse) F3
holding APLS Common Stock 150K Dec 15, 2022 Indirect Owner (Spouse Trust) F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -1.25K -1.09% $0.00 114K Dec 15, 2022 Common Stock 1.25K $2.67 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise and sale from 10B5-1 trading plan.
F2 The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
F3 Owned by spouse.
F4 On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.
F5 This option was granted on December 5, 2013 and fully vested.